Navigating the Selective Window: PwC’s Mike Bellin on the 2026–2027 U.S. IPO Market, AI Valuations, and Biotech’s Resurgence
Executive Overview The U.S. initial public offering (IPO) market has undergone a significant transformation over the past several cycles. After a prolonged...
